RecurrentClostridium difficileInfection: Risk Factors, Treatment, and Prevention
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2019/01/15
-
Journal
-
Indian UGC (journal)
-
Refrences96
-
Citations95
-
Jung Hoon Song Department of Internal Medicine, Seoul Red Cross Hospital, Seoul, Korea
-
You Sun Kim Department of Internal Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea
Cite
Song, Jung Hoon, and You Sun Kim. “RecurrentClostridium DifficileInfection: Risk Factors, Treatment, and Prevention”. Gut and Liver, vol. 13, no. 1, 2019, pp. 16-24, https://doi.org/10.5009/gnl18071.
Song, J. H., & Kim, Y. S. (2019). RecurrentClostridium difficileInfection: Risk Factors, Treatment, and Prevention. Gut and Liver, 13(1), 16-24. https://doi.org/10.5009/gnl18071
Song JH, Kim YS. RecurrentClostridium difficileInfection: Risk Factors, Treatment, and Prevention. Gut and Liver. 2019;13(1):16-24.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the digestive system
Gastroenterology
Medicine
Medicine (General)
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Guideline for Hand Hygiene in Health-Care Settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force | Infection Control & Hospital Epidemiology |
| 725 | 2002 |
| Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis | Gastroenterology |
| 302 | 1978 |
| 10.1128/JCM.38.6.2386-2388.2000 | ||||
| Vaccines in development for the primary prevention of Clostridium difficile infection | Journal of the American Pharmacists Association |
| 4 | 2017 |
| A Review of the Safety and Efficacy of Vaccines as Prophylaxis for Clostridium difficile Infections | Vaccines |
| 16 | 2017 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Clostridioides difficile recurrence in individuals with and without cancer: a Swedish population-based cohort study | Infection |
| 2024 | |
| A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States | Infectious Diseases and Therapy |
| 2024 | |
| Recurrence of Clostridioides difficile infection and mortality in older inpatients | European Geriatric Medicine |
| 2024 | |
| The effect of antibiotic therapy for Clostridioides difficile infection on mortality and other patient-relevant outcomes: a systematic review and meta-analysis | Clinical Microbiology and Infection |
| 3 | 2024 |
| Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study | International Journal of Infectious Diseases |
| 1 | 2024 |
Citations Analysis
The category
Science: Microbiology 41
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Design and Expression of Specific Hybrid Lantibiotics Active Against Pathogenic Clostridium spp. and was published in 2019. The most recent citation comes from a 2024 study titled Clostridiodes difficile infection in inflammatory bowel disease: a clinical review. This article reached its peak citation in 2023, with 33 citations. It has been cited in 72 different journals, 47% of which are open access. Among related journals, the Anaerobe cited this research the most, with 5 citations. The chart below illustrates the annual citation trends for this article.